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Introduction
Multifocal motor neuropathy (MMN) is an immune-mediated 
disorder with predominantly distal, mainly upper limb, asym-
metrical manifestations, and pure motor neuropathy.
1-3 The 
hallmark of MMN is the presence of conduction block in mo-
tor nerve conduction studies (NCSs). MMN is a treatable disor-
der, with about 80% of patients responding to intravenous im-
munoglobulin.
2,4 For this reason, it needs to be distinguished from 
motor neuron disease, which is much more common but remains 
untreatable. The pathogenesis of the disease is still unknown, 
but there is some evidence, based mainly on the clinical improve-
ment of patients after immunological treatments, that MMN is 
related to an immune disorders.
3 MMN is also frequently asso-
ciated with antiganglioside antibodies to monosialoganglioside 
(GM1), and disialoganglioside (GD1b) of the IgM type.
5 Gan-
gliosides are sialic acids containing glycosphingolipids that are 
particularly abundant in the neural membranes of the nervous sys-
tem; they are also detected in thyroid cells.
3,5,6 Antibodies against 
the main gangliosides, such as GM1 and GD1b, are found in pa-
tients with MMN, which suggests an autoimmune pathogenic 
mechanism. 
Hashimoto’s thyroiditis is one of the most frequent causes of 
primary hypothyroidism and a well-known immune-associated 
disease; circulating thyroid autoantibodies are usually detect-
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BackgroundzzMultifocal motor neuropathy (MMN) is an immune-mediated disorder that is 
characterized by slowly progressive and asymmetrical weakness, but its pathophysiological 
mechanism is uncertain. The hypothesis that MMN is an immunological disease has been sup-
ported by the proven therapeutic effects of intravenous immunoglobulin and the detection of an-
tiganglioside antibodies in MMN patients. The coexistence of MMN with other immune diseas-
es has been rarely reported.
Case ReportzzA 37-year-old woman visited our hospital complaining of weakness in both 
hands. The clinical manifestations coincided well with MMN: predominantly distal upper-limb 
weakness, asymmetric involvement, a progressive course, absence of sensory symptoms, ab-
sence of pyramidal signs, and sparing of the cranial muscles. The electrophysiological findings 
also supported a diagnosis of MMN, with motor nerve conduction block in the median, ulnar, 
and radial nerves, without sensory nerve involvement. The patient was simultaneously diag-
nosed as having Hashimoto’s thyroiditis, which is a well-known immune-mediated disease.
ConclusionszzThe concurrence of MMN and Hashimoto’s thyroiditis in our patient is signifi-
cant for understanding the immunological characteristics of the two diseases.
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7 The histopathologic findings of Hashimoto’s disease show 
widespread lymphocyte infiltration in the thyroid tissue.
8 Other 
autoimmune diseases may also occur in patients with Hashimo-
to’s disease.
9 However, the coincidence of MMN and Hashimo-
to’s thyroiditis has rarely been reported, and the pathophysiol-
ogy has been limitedly clarified. 
We report herein an unusual case of MMN accompanied si-
multaneously by Hashimoto’s thyroiditis.
Case Report
A 37-year-old woman visited our hospital complaining of weak-
ness in both hands. Five years prior to admission, she had no-
ticed mild weakness of insidious onset in her left hand. How-
ever, she did not undergo medical treatment or visit clinics. 
Weakness developed in her right hand 2 years later. The weak-
ness in both hands progressed gradually and the severity in-
creased. She began to experience difficulty in writing, handling 
chopsticks, and making a fist. The patient visited local clinics, 
but was not sufficiently evaluated. On admission the patient had 
severe weakness and muscle atrophy in both hands, without 
sensory change. Her past medical history and the antenatal and 
postnatal periods had been uneventful. She had attended school 
and had led an apparently normal life until she noticed neuro-
logical manifestations. Relevant diseases, a familial history of 
neurological disease, smoking, and alcohol were not noted. She 
had taken an antihypertension drug and oral thyroid hormone at 
a local clinic. On examination, her vitals sign were stable, with 
a blood pressure of 140/90 mmHg and a heart rate of 72 beats/
min. A neurological examination revealed that she was alert and 
her orientation was intact. Cognitive impairment was not detect-
ed. There were no abnormal findings on cranial nerve exami-
nation.
Motor system examinations using the Medical Research Coun-
cil (MRC) grade revealed severe motor weakness in both hands 
(flexor pollicis longus, MRC grades 3/5 and 2/5 on the right and 
left, respectively; flexor digitorum profundus and sublimis, MRC 
grades 3/5 and 3/5; flexor carpi ulnaris and radialis, MRC grades 
3/5 and 3/5; extensor pollicis brevis and longus, MRC grades 
3/5 and 2/5; extensor carpi radialis, MRC grade 3/5 and 2/5; 
extensor carpi ulnaris, MRC grades 3/5 and 3/5; extensor digi-
torum communis, MRC grades 2/5 and 2/5; abductor pollicis 
brevis, MRC grades 3/5 and 3/5; and abductor digiti minimi, 
MRC grades 2/5 and 2/5). Prominent muscle atrophy and de-
formities were observed distally in both hands (Fig. 1A). The 
motor power of both lower extremities was normal. The deep 
tendon reflex was decreased in the upper extremities.
The patient exhibited symmetric and intact responses to all 
sensory stimuli, and her cortical senses were intact. Her neck 
was supple, no carotid bruit was audible, and the results of a cer-
ebellar function test were normal.
Laboratory investigations revealed a normal hemogram, se-
rum electrolytes, and renal function. Cerebrospinal fluid find-
ings were normal. Evaluations for vasculitis involving rheuma-
toid factor, anti-dsDNA antibody, lupus anticoagulant, anticar-
diolipin antibody, antithrombin III, antineutrophil cytoplasmic 
antibody, anti-SSA and SSB (Sjogren syndrome A and B) an-
tibody, complement 3/4, anti-jo-1 antibody, cryoglobulin, im-
munofixation electrophoresis/protein electrophoresis, anti-
GM1 antibody, and anti-GD1b antibody were within the nor-
mal range or negative, with the exception of a mildly elevated 
fluorescent antinuclear antibody titer (1 : 40). The results of tu-
mor screening tests involving alpha-fetoprotein, carcinoembry-
onic antigen, cancer antigen (CA)-19-9, and CA-125 were nor-
mal. Hexosaminidases A and B, and creatine kinase were also 
within the normal ranges. However, a thyroid function test re-
vealed an abnormally elevated antithyroglobulin antibody titer 
(794 U/mL, normal range: 0-100 U/mL) and antimicrosomal an-
tibody (26,030 U/mL, normal range: 0-100 U/mL), but the thy-
roid hormone levels, including T3, free T4, and thyroid stimu-
lating hormone, were normal.
Cervical magnetic resonance imaging revealed no prominent 
abnormalities except mild disc protrusion at the C5-6 and C6-7 
levels. NCSs and electromyography were performed using stan-
dard techniques of percutaneous supramaximal stimulation and 
recordings. These examinations revealed motor neuropathies in 
the median motor nerve, ulnar motor nerve, and radial motor 
nerve, with definite motor conduction block manifesting as the 
compound muscle action potential amplitude being more than 
50% lower for proximal than for distal stimulation across a stan-
dard peripheral nerve segment (Fig. 2). However, the findings 
of sensory NCSs in the upper extremities, and motor and sen-
B  
Fig. 1. Deformities of both hands in our 
patient. Severe deformities in the right 
hand (A) were much improved (B) after 
treatment with high-dose intravenous 
immunoglobulin (0.4 g/kg/day) for 5 con-
secutive days. A  MMN with Hashimoto’s Thyroiditis
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sory NCSs in the lower extremities were normal. Thus, even th-
ough the patient was negative for antiganglioside antibodies, 
the electrophysiological study and clinical manifestations re-
sulted in a diagnosis of MMN.
A biopsy of the patient’s thyroid tissue by ultrasound-guided 
aspiration revealed diffuse lymphocyte infiltration, a finding that 
is consistent with Hashimoto’s thyroiditis (Fig. 3). She was 
treated with high-dose intravenous immunoglobulin (0.4 g/kg/
day) for 5 consecutive days and then discharged. When she vis-
ited our Outpatient Department 1 month later, the weakness and 
B  
Fig. 3. Microscopy findings of a biopsy 
sample of the patient’s thyroid tissue re-
veal diffuse lymphocyte infiltration (black 
arrows) and a few sheets of follicular 
epithelial cells (white arrows) without 
malignant cells (Papanicolaou staining: 
A, ×200; B, ×400). A  
Fig. 2. Raw data of nerve conduction studies (NCSs) of the patient’s right median motor nerve (A), left median motor nerve (B), right ulnar 
motor nerve (C), left ulnar motor nerve (D), right radial motor nerve (E), and left radial motor nerve (F). The raw data shown on the left and 
right sides of the arrow correspond to before and after treatment, respectively. Before intravenous immunoglobulin therapy, the NCSs re-
vealed conduction block in right median motor nerve, left median motor nerve, right ulnar motor nerve, left ulnar motor nerve and left radial 
nerve. One month later, after high-dose intravenous immunoglobulin therapy, conduction blocks were improved, especially for the left median 
motor nerve, right ulnar motor nerve, and left radial motor nerve. F-W: finger-wrist, W-E: wrist-elbow, E-Ax: elbow-axilla, W-B.E: wrist-below el-
bow, B.E-A.E: below elbow-above elbow, A.E-Ax: above elbow-axilla.
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deformity in her right hand was considerably improved (Fig. 
1B) and the conduction block of the motor nerves were mildly 
improved, as evaluated by follow-up NCSs (Fig. 2). This patient 
will be continuously followed up at the Outpatient Department.
Discussion
The case presented herein is characterized by an association 
between MMN and Hashimoto’s thyroiditis. The clinical pre-
sentation was typical for MMN, since such patients complain 
predominantly of progressively worsening upper-limb weakness 
(mainly distal), asymmetric involvement, absence of sensory 
symptoms, absence of pyramidal signs, and sparing of the cra-
nial muscles.
1,2 The electrophysiological findings also sup-
ported a diagnosis of MMN, with motor nerve conduction block 
in the median, ulnar, and radial nerves, without sensory nerve 
involvement.
The most important investigations for determining MMN 
are electrophysiological studies, and in particular motor NCSs, 
for which the main finding in MMN is a persistent multifocal 
conduction block.
1,2,5 Conduction block manifests as a lower 
compound muscle action potential amplitude or a smaller area 
on electrical stimulation of a nerve at a proximal site, compared 
to a distal site. Although conduction block is characteristic of 
MMN, it may be found in several other disorders such as Guil-
lain-Barré syndrome, chronic inflammatory demyelinating poly-
neuropathy, and nerve ischemia.
10,15 Therefore, the appropriate 
interpretation of a conduction block also requires consideration 
of the clinical presentation.
10 Our patient could be clinically dif-
ferentiated from Guillain-Barré syndrome, chronic inflamma-
tory demyelinating polyneuropathy, and nerve ischemia since 
she complained of slowly progressing, asymmetric motor weak-
ness in the distal upper extremity, without sensory symptoms. 
According to the clinical manifestations, electrophysiological 
study findings, and response to intravenous immunoglobulin, a 
diagnosis of MMN in our patient was reasonable, although she 
was negative for antiganglioside antibodies related to MMN. 
Elevated antiganglioside antibody titers are a typical finding; 
however, the sensitivity of this measure is uncertain, reportedly 
varying between 30% and 80% (although usually lying between 
40% and 50%).
1,2,5 In addition, these antibodies are not specific 
for MMN, having been found in about 10% of cases of the pure 
lower motor neuron variant of motor neuron disease.
5 Therefore, 
the negative antiganglioside antibody finding did not rule out a 
diagnosis of MMN in the case reported here.
The pathophysiology of MMN is believed to be focal motor 
nerve demyelination, resulting in conduction block. However, 
this remains uncertain, and an immune-mediated origin of MMN 
is suspected on the basis of the presence of antiganglioside an-
tibodies and response to immune intervention. The ganglioside 
GM1, which is abundant in motor nerves at the nodes of Ran-
vier and motor end plates, may be the target of an immune re-
sponse, resulting in conduction block.
3,5 In vivo and in vitro ex-
periments have demonstrated that the serum from patients with 
MMN and anti-GM1 antibodies induces focal conduction block 
after intraneural injection.
11 Disruption of the blood-nerve bar-
rier by these antibodies has also been hypothesized as a possi-
ble mechanism.
12 However, about 50% of reported cases of 
MMN are negative for anti-GM1 antibodies.
5 Despite a prob-
able autoimmune basis, the precise mechanism underlying the 
development of MMN is still poorly understood.
On admission to our hospital, our patient was additionally di-
agnosed as having Hashimoto’s thyroiditis, which is a well-
known autoimmune disease and one of the most frequent 
causes of primary hypothyroidism. The prevalence of various 
diseases with autoimmune components in patients with Hashi-
moto’s thyroiditis and in their relatives is higher than can be ac-
counted for by chance.
7-9 The plasma membranes of thyrocytes 
are also very rich in ganglioside, and these are particularly abun-
dant in neural membranes, inducing specific antibodies for 
MMN.
6,13 The high concentrations of gangliosides in both neu-
ral and thyroid tissues had led to some authors suggesting a 
pathogenic relationship between MMN and Hashimoto’s thy-
roiditis and a potential immunological interaction between an-
tiganglioside antibodies and both neural and thyroid tissues.
14 
Unfortunately, antiganglioside antibodies were not detected in 
our case.
The reported variations in the prevalence of these antibod-
ies in MMN have been variably attributed to technical differenc-
es in the procedures adopted by different laboratories, differenc-
es in the controls used to establish normal reference values, and 
differences in the disease period tested for MMN. The reasons 
for such a wide variation in the percentage of abnormal findings 
remain to be elucidated.
MMN is a rarely described, treatable, immune-mediated mo-
tor nerve disease; however, there are many remaining uncertain-
ties about the precise underlying pathophysiological mecha-
nisms. Therefore, the case reported here is significant in that it 
demonstrates a possible link and pathophysiological mechanism 
between MMN and a more common autoimmune disease, Ha-
shimoto’s thyroiditis.
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